每日牛股追蹤 | 港股有7只股票創新高，綠城中國（03900）大漲3.96%，近一年漲幅達86.98%
截至9月15日收盤，港股有7只股票創新高，分別爲綠城中國（03900）、越秀地產（00123）、綠城管理控股（09979）、華潤醫藥（03320）、新秀麗（01910）、中國財險（02328）、中遠海能（01138）。（注：統計港股市場上市值>100億港元、成交額>1000萬港元，上市時間>1個月的股票）
綠城中國（03900）盤中最高觸達18.28港元，創歷史新高，近一年漲幅86.98%。該股收盤上漲3.96%，報17.86港元。中金指，受近期各地疫情散發影響，內地新房銷售或階段性承壓，預計支持購房需求和保交樓、穩預期的相關政策仍有望繼續加碼，以加速基本面修復，在這一過程中財務穩健、土儲優質、拿地積極的均好型房企受益最大。
越秀地產（00123）盤中最高觸達11.2港元，創歷史新高，近一年漲幅60.22%。該股收盤上漲3.58%，報10.98港元。
綠城管理控股（09979）盤中最高觸達7.19港元，創歷史新高，近一年漲幅82.81%。該股收盤上漲1.73%，報7.04港元。
華潤醫藥（03320）盤中最高觸達5.99港元，創52周新高，近一年漲幅49.27%。該股收盤上漲1.36%，報5.95港元。野村發表報告表示，在中國從事受託研究機構(CRO)行業的股份已呈超賣，並預計該行業將獲得一些進展。 該行又指，美方行政命令以及要實施的詳細舉措涵蓋了廣泛的領域，包括生物供應鏈、生物製造、生物產品，從原料藥、燃料、聚合物、肥料廢物和氣候變化。該行認為相關命令不是特別針對某一國家的生物技術或CRO行業，影響有限。
新秀麗（01910）盤中最高觸達20.9港元，創52周新高，近一年漲幅38.17%。該股收盤上漲0.91%，報19.98港元。匯豐研究發報告稱，新秀麗2022年上半年業績大幅好過預期。該行將新秀麗2022-2024年經調整EBITDA預測下調4%，以反映外匯計算和業務再投資。但基於折讓現金流計價模式展期一年。維持“買入”評級，目標價由23元上調至27元。
中國財險（02328）盤中最高觸達8.87港元，創52周新高，近一年漲幅37.14%。該股收盤上漲0.23%，報8.87港元。中國財險發佈公告，公司2022年1月1日至8月31日的原保險保費收入合計人民幣3402.47億元，同比增長9.8%。
中遠海能（01138）盤中最高觸達7.47港元，創52周新高，近一年漲幅131.65%。該股收盤下跌4.71%，報6.88港元。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
